perimenopause glp 1 GLP-1 Weight Loss in Menopause: How HRT Amplifies Results Metabolism + Perimenopause Support Set

Bakand A, Moghaddam SV, Naseroleslami M, Andre H, Mousavi-Niri N, Alizadeh E

The treatment involves a tailored infusion of nutrients, vitamins, and anti-inflammatory agents to help reduce gut inflammation, repair damaged intestinal tissues, and support overall digestive health

Post-surgical gut recovery: BPC-157 + KPV

This maximizes tolerance but significantly extends time to optimal dosing, potentially losing patients to frustration before benefits fully manifest

Article Summary: Popular treatments like Mounjaro and Wegovy are shown to deliver weight loss results

Phase 2 cagrilintide alone ~10.8% body weight reduction at 26 weeks (4.5mg) Phase 2 CagriSema combo ~15.6% body weight reduction at 32 weeks Phase 3 REDEFINE 1 ~22.7% body weight reduction at 68 weeks Phase 2 CagriSema combination trial The Phase 2 trial of CagriSema was published in The Lancet in 2023, and its results attracted immediate attention